Interleukin 17A rs4711998 A>G polymorphism was associated with a decreased risk of esophageal cancer in a Chinese population

被引:34
作者
Yin, J. [1 ]
Wang, L. [2 ]
Shi, Y. [1 ]
Shao, A. [1 ]
Tang, W. [1 ]
Wang, X. [1 ]
Ding, G. [1 ]
Liu, C. [1 ]
Chen, S. [1 ]
Gu, H. [1 ]
机构
[1] Jiangsu Univ, Dept Cardiothorac Surg, Affiliated Peoples Hosp, Zhenjiang 212000, Peoples R China
[2] Jiangsu Univ, Inst Mol Biol & Translat Med, Affiliated Peoples Hosp, Zhenjiang 212000, Peoples R China
基金
中国国家自然科学基金;
关键词
esophageal cancer; IL17A; molecular epidemiology; polymorphism; GENOME-WIDE ASSOCIATION; SQUAMOUS-CELL CARCINOMA; GENETIC-VARIANTS; T-CELLS; IL-17; EXPRESSION; STATISTICS; RECEPTOR; DISEASE; FAMILY;
D O I
10.1111/dote.12045
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Esophageal cancer is the eighth most common cancer and sixth leading cause of cancer-associated death worldwide. Besides environmental risk factors, genetic factors might play an important role in the esophageal cancer carcinogenesis. We conducted a hospital-based case-control study to evaluate the genetic effects of functional single nucleotide polymorphisms (SNPs) in the interleukin 17A (IL17A) gene on the development of esophageal cancer. A total of 380 esophageal squamous cell carcinoma (ESCC) cases and 380 controls were recruited for this study. The genotypes were determined using a custom-by-design 48-Plex SNPscan Kit. IL17A rs4711998 A>G polymorphism was associated with the decreased risk of ESCC. When the IL17A rs4711998 AA homozygote genotype was used as the reference group, the AG genotype was associated with a significantly decreased risk for ESCC (AG vs. AA: adjusted odds ratio 0.72, 95% confidential interval 0.53-0.98, P = 0.039). However, there was no significant association between the other five SNPs and ESCC risk. Stratified analyses indicated that a significantly decreased risk of ESCC associated with the IL17A rs4711998 A>G polymorphism was evident among younger patients and patients who never smoking or drinking. These findings indicated that functional polymorphism IL17A rs4711998 A>G might contribute to ESCC susceptibility. However, our results were obtained with a limited sample size; the power of our analysis was low. Future larger studies with more rigorous study designs of other ethnic populations are required to confirm current findings.
引用
收藏
页码:87 / 92
页数:6
相关论文
共 24 条
[1]   Serum interleukin-17 and its relationship to angiogenic factors in multiple myeloma [J].
Alexandrakis, Michael G. ;
Pappa, Constantina A. ;
Miyakis, Spiros ;
Sfiridaki, Aikaterini ;
Kafousi, Maria ;
Alegakis, Athanassios ;
Stathopoulos, Efstathios N. .
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2006, 17 (06) :412-416
[2]   Intratumoral Expression of IL-17 and Its Prognostic Role in Gastric Adenocarcinoma Patients [J].
Chen, Ju-gao ;
Xia, Jian-chuan ;
Liang, Xiao-ting ;
Pan, Ke ;
Wang, Wei ;
Lv, Lin ;
Zhao, Jing-jing ;
Wang, Qi-jing ;
Li, Yong-qiang ;
Chen, Shi-ping ;
He, Jia ;
Huang, Li-xi ;
Ke, Miao-la ;
Chen, Yi-bing ;
Ma, Hai-qing ;
Zeng, Zhen-wu ;
Zhou, Zhi-wei ;
Chang, Alfred E. ;
Li, Qiao .
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2011, 7 (01) :53-60
[3]   Genome-wide association study validation identifies novel loci for atherosclerotic cardiovascular disease [J].
Chen, X. ;
Li, S. ;
Yang, Y. ;
Yang, X. ;
Liu, Y. ;
Liu, Y. ;
Hu, W. ;
Jin, L. ;
Wang, X. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (08) :1508-1514
[4]   Cancer statistics, 2008 [J].
Jemal, Ahmedin ;
Siegel, Rebecca ;
Ward, Elizabeth ;
Hao, Yongping ;
Xu, Jiaquan ;
Murray, Taylor ;
Thun, Michael J. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2008, 58 (02) :71-96
[5]   Expression of IL-17 mRNA in ovarian cancer [J].
Kato, T ;
Furumoto, H ;
Ogura, T ;
Onishi, Y ;
Irahara, M ;
Yamano, S ;
Kamada, M ;
Aono, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 282 (03) :735-738
[6]   Interleukin-17 family members and inflammation [J].
Kolls, JK ;
Lindén, A .
IMMUNITY, 2004, 21 (04) :467-476
[7]   Crucial role for nuclear factor of activated T cells in T cell receptor-mediated regulation of human interleukin-17 [J].
Liu, XKK ;
Lin, X ;
Gaffen, SL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (50) :52762-52771
[8]  
MACFARLANE GJ, 1994, J ROY SOC MED, V87, P334
[9]   Mechanisms of Disease: Interleukin-17 and Type 17 Helper T Cells. [J].
Miossec, Pierre ;
Korn, Thomas ;
Kuchroo, Vijay K. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (09) :888-898
[10]   Interleukin-17 family and IL-17 receptors [J].
Moseley, TA ;
Haudenschild, DR ;
Rose, L ;
Reddi, AH .
CYTOKINE & GROWTH FACTOR REVIEWS, 2003, 14 (02) :155-174